Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial
Latest Information Update: 21 Sep 2022
At a glance
- Drugs Interferon alpha-2a (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Ainos; Amarillo Biosciences
- 13 Oct 2009 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Planned end date changed from 1 Mar 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.